Rigorous human evidence is the central premise of our proposal. Given the complexity of cellular pathology, the profound temporal changes in risk profiles, the preventive treatment of patients, and the underlying pathological substrate, we assert that evidence from human observations is key to the identification of regulatory mechanisms that determine plaque destabilization and stabilization.

Such evidence will further be complemented through validation in both human in vitro and preclinical cellular and animal model studies.